Use of Conservative Therapies Before Hysterectomy for Uterine Leiomyomas

Obstet Gynecol. 2023 Feb 1;141(2):371-374. doi: 10.1097/AOG.0000000000005053. Epub 2023 Jan 4.

Abstract

We used a claims database to identify patients with uterine leiomyomas who underwent hysterectomy between 2011 and 2019. Use of conservative medical and surgical interventions in the 24-month period before hysterectomy was explored. Overall, 59.7% of patients did not receive any conservative intervention before hysterectomy. Individuals who underwent hysterectomy in more recent years and those with endometriosis, abnormal bleeding, greater comorbidity, or prior venous thromboembolism were more likely to receive conservative interventions.

MeSH terms

  • Conservative Treatment
  • Endometriosis* / surgery
  • Female
  • Humans
  • Hysterectomy
  • Leiomyoma* / surgery
  • Uterine Neoplasms* / surgery